248 related articles for article (PubMed ID: 18811807)
1. Long-term prognostic value of baseline C-reactive protein in predicting recurrence of atrial fibrillation after electrical cardioversion.
Korantzopoulos P; Kalantzi K; Siogas K; Goudevenos JA
Pacing Clin Electrophysiol; 2008 Oct; 31(10):1272-6. PubMed ID: 18811807
[TBL] [Abstract][Full Text] [Related]
2. Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion.
Loricchio ML; Cianfrocca C; Pasceri V; Bianconi L; Auriti A; Calo L; Lamberti F; Castro A; Pandozi C; Palamara A; Santini M
Am J Cardiol; 2007 May; 99(10):1421-4. PubMed ID: 17493472
[TBL] [Abstract][Full Text] [Related]
3. The effect of sinus rhythm restoration on high-sensitivity C-reactive protein levels and their association with long-term atrial fibrillation recurrence after electrical cardioversion.
Celebi OO; Celebi S; Canbay A; Ergun G; Aydogdu S; Diker E
Cardiology; 2011; 118(3):168-74. PubMed ID: 21654170
[TBL] [Abstract][Full Text] [Related]
4. High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion.
Watanabe E; Arakawa T; Uchiyama T; Kodama I; Hishida H
Int J Cardiol; 2006 Apr; 108(3):346-53. PubMed ID: 15964643
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of hs-CRP and IL-6 in patients with persistent atrial fibrillation treated with electrical cardioversion.
Henningsen KM; Therkelsen SK; Bruunsgaard H; Krabbe KS; Pedersen BK; Svendsen JH
Scand J Clin Lab Invest; 2009; 69(3):425-32. PubMed ID: 19204850
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between C-reactive protein level and early recurrence of atrial fibrillation after electrical cardioversion].
Zarauza J; Rodríguez Lera MJ; Fariñas Alvarez C; Hernando JP; Ceballos B; Gutiérrez B; Pérez J; Cuesta JM
Rev Esp Cardiol; 2006 Feb; 59(2):125-9. PubMed ID: 16540033
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of the high-sensitive C-reactive protein in the catheter ablation of atrial fibrillation.
Lin YJ; Tsao HM; Chang SL; Lo LW; Tuan TC; Hu YF; Udyavar AR; Tsai WC; Chang CJ; Tai CT; Lee PC; Suenari K; Huang SY; Nguyen HT; Chen SA
Am J Cardiol; 2010 Feb; 105(4):495-501. PubMed ID: 20152244
[TBL] [Abstract][Full Text] [Related]
8. Baseline apnoea/hypopnoea index and high-sensitivity C-reactive protein for the risk of recurrence of atrial fibrillation after successful electrical cardioversion: a predictive model based upon the multiple effects of significant variables.
Mazza A; Bendini MG; Cristofori M; Nardi S; Leggio M; De Cristofaro R; Giordano A; Cozzari L; Giordano G; Cappato R
Europace; 2009 Jul; 11(7):902-9. PubMed ID: 19443431
[TBL] [Abstract][Full Text] [Related]
9. The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation.
Kallergis EM; Manios EG; Kanoupakis EM; Mavrakis HE; Kolyvaki SG; Lyrarakis GM; Chlouverakis GI; Vardas PE
Heart; 2008 Feb; 94(2):200-4. PubMed ID: 17575330
[TBL] [Abstract][Full Text] [Related]
10. High sensitivity C-reactive protein: a novel predictor for recurrence of atrial fibrillation after successful cardioversion.
Malouf JF; Kanagala R; Al Atawi FO; Rosales AG; Davison DE; Murali NS; Tsang TS; Chandrasekaran K; Ammash NM; Friedman PA; Somers VK
J Am Coll Cardiol; 2005 Oct; 46(7):1284-7. PubMed ID: 16198844
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of association between C-reactive protein and immediate success of electrical cardioversion in persistent atrial fibrillation.
Liu T; Li L; Korantzopoulos P; Goudevenos JA; Li G
Am J Cardiol; 2008 Jun; 101(12):1749-52. PubMed ID: 18549852
[TBL] [Abstract][Full Text] [Related]
12. Serum amyloid a and C-reactive protein independently predict the recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function.
Barassi A; Pezzilli R; Morselli-Labate AM; Lombardi F; Belletti S; Dogliotti G; Corsi MM; Merlini G; Melzi d'Eril GV
Can J Cardiol; 2012; 28(5):537-41. PubMed ID: 22552174
[TBL] [Abstract][Full Text] [Related]
13. Statins and amiodarone improve freedom from recurrence of atrial fibrillation after successful cardioversion.
Naji F; Suran D; Kanic V; Vokac D; Sabovic M
Med Sci Monit; 2009 Sep; 15(9):CR494-8. PubMed ID: 19721402
[TBL] [Abstract][Full Text] [Related]
14. Effect of atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion.
Ozaydin M; Varol E; Aslan SM; Kucuktepe Z; Dogan A; Ozturk M; Altinbas A
Am J Cardiol; 2006 May; 97(10):1490-3. PubMed ID: 16679090
[TBL] [Abstract][Full Text] [Related]
15. N-3 polyunsaturated fatty acids administration does not reduce the recurrence rates of atrial fibrillation and inflammation after electrical cardioversion: a prospective randomized study.
Ozaydın M; Erdoğan D; Tayyar S; Uysal BA; Doğan A; Içli A; Ozkan E; Varol E; Türker Y; Arslan A
Anadolu Kardiyol Derg; 2011 Jun; 11(4):305-9. PubMed ID: 21543294
[TBL] [Abstract][Full Text] [Related]
16. Comparison of atrial fibrillation recurrence rates after successful electrical cardioversion in patients with hyperthyroidism-induced versus non-hyperthyroidism-induced persistent atrial fibrillation.
Siu CW; Jim MH; Zhang X; Chan YH; Pong V; Kwok J; Kung AW; Lau CP; Tse HF
Am J Cardiol; 2009 Feb; 103(4):540-3. PubMed ID: 19195517
[TBL] [Abstract][Full Text] [Related]
17. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome.
Boriani G; Diemberger I; Biffi M; Domenichini G; Martignani C; Valzania C; Branzi A
Int J Clin Pract; 2007 May; 61(5):748-56. PubMed ID: 17493088
[TBL] [Abstract][Full Text] [Related]
18. Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation.
Hatzinikolaou-Kotsakou E; Tziakas D; Hotidis A; Stakos D; Floros D; Papanas N; Chalikias G; Maltezos E; Hatseras DI
Am J Cardiol; 2006 Mar; 97(5):659-61. PubMed ID: 16490433
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein is a risk indicator for atrial fibrillation after myocardial revascularization.
Lo B; Fijnheer R; Nierich AP; Bruins P; Kalkman CJ
Ann Thorac Surg; 2005 May; 79(5):1530-5. PubMed ID: 15854929
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein but not atrial dysfunction predicts recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function.
Lombardi F; Tundo F; Belletti S; Mantero A; Melzi D'eril GV
J Cardiovasc Med (Hagerstown); 2008 Jun; 9(6):581-8. PubMed ID: 18475126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
